Neulasta Onpro Hematopoietic Agent Pegfilgrastim 6 mg / 0.6 mL Subcutaneous Injection Prefilled Syringe 1 Kit , Amgen 55513019201
TERMS & CONDITIONS FOR PURCHASING INJECTABLES & MEDICATIONS :
1- REGULATIONS ON PURCHASE OF INJECTABLES & MEDICATIONS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE.
2- INJECTABLES & MEDICATIONS WOULD BE SOLD ONLY TO QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , DENTAL OFFICES , HEALTH CARE PROVIDERS , .... ) WITH VALID MEDICAL LICENSE.
3- ORDERS INCLUDING PURCHSE OF INJECTABLES & MEDICATIONS WOULD BE PROCESSED AFTER VERIFICATION OF PURCHASER'S VALID MEDICAL LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )
Manufacturer # | 55513019201 |
Brand | Neulasta® Onpro™ |
Manufacturer | Amgen Inc |
Application | Hematopoietic Agent |
Container Type | Prefilled Syringe |
Dosage Form | Injection |
Generic Drug Code | 37706 |
Generic Drug Name | Pegfilgrastim |
NDC Number | 55513-0192-01 |
Storage Requirements | Requires Refrigeration |
Strength | 6 mg / 0.6 mL |
Type | Subcutaneous |
UNSPSC Code | 51201803 |
Volume | 1 Kit |
Features
- Neulasta® helps reduce the risk of infection by boosting your white blood cell count to strengthen your immune system
- Neulasta® (pegfilgrastim) is a prescription medicine used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid), who receive anti-cancer medicines that can cause fever and low blood cell count
- The Neulasta® Onpro™ kit includes a single dose of Neulasta® and a single-use On-body Injector
- The On-body Injector is a small, lightweight delivery system applied to the skin during your chemo appointment
- It's designed to automatically deliver your dose of Neulasta® the next day, so you may not have to return to the doctor just for a Neulasta® shot